Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

BACKGROUND: This randomized, open-label trial aimed to compare the efficacy of 10-day bismuth-containing quadruple therapy (BQT) with 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT) as an empirical first-line Helicobacter pylori therapy. METHODS: Participants with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Il, Lee, Jong Yeul, Kim, Chan Gyoo, Park, Boram, Park, Jin Young, Choi, Il Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923489/
https://www.ncbi.nlm.nih.gov/pubmed/33653284
http://dx.doi.org/10.1186/s12876-021-01680-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923489/
https://www.ncbi.nlm.nih.gov/pubmed/33653284
http://dx.doi.org/10.1186/s12876-021-01680-1

Ejemplares similares